Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Case Presentation: Clinical History and Findings
3.2. Literature Review
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- Ferlay, J.; Colombet, M.; Soerjomataram, I.; Parkin, D.M.; Piñeros, M.; Znaor, A.; Bray, F. Cancer statistics for the year 2020: An overview. Int. J. Cancer 2021, 149, 778–789. Available online: https://pubmed.ncbi.nlm.nih.gov/33818764/ (accessed on 5 May 2024). [CrossRef] [PubMed]
- Russo, A.; Li, P.; Strong, V.E. Differences in the multimodal treatment of gastric cancer: East versus west. J. Surg. Oncol. 2017, 115, 603–614. [Google Scholar] [CrossRef]
- Markar, S.R.; Karthikesalingam, A.; Jackson, D.; Hanna, G.B. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: Comparison between West and East. Ann. Surg. Oncol. 2013, 20, 2328–2338. [Google Scholar] [CrossRef]
- Garbarino, G.M.; Laracca, G.G.; Lucarini, A.; Piccolino, G.; Mercantini, P.; Costa, A.; Tonini, G.; Canali, G.; Muttillo, E.M.; Costa, G. Laparoscopic versus Open Surgery for Gastric Cancer in Western Countries: A Systematic Review and Meta-Analysis of Short- and Long-Term Outcomes. J. Clin. Med. 2022, 11, 3590. [Google Scholar] [CrossRef]
- Ajani, J.A.; D’Amico, T.A.; Bentrem, D.J.; Chao, J.; Cooke, D.; Corvera, C.; Das, P.; Enzinger, P.C.; Enzler, T.; Fanta, P.; et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. 2022, 20, 167–192. Available online: https://pubmed.ncbi.nlm.nih.gov/35130500/ (accessed on 5 May 2024). [CrossRef]
- Lordick, F.; Carneiro, F.; Cascinu, S.; Fleitas, T.; Haustermans, K.; Piessen, G.; Vogel, A.; Smyth, E. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 2022, 33, 1005–1020. Available online: http://www.annalsofoncology.org/article/S0923753422018518/fulltext (accessed on 5 May 2024). [CrossRef] [PubMed]
- Riihimaki, M.; Hemminki, A.; Sundquist, K.; Sundquist, J.; Hemminki, K. Metastatic spread in patients with gastric cancer. Oncotarget 2016, 7, 52307–52316. Available online: https://pubmed.ncbi.nlm.nih.gov/27447571/ (accessed on 5 May 2024). [CrossRef]
- Cavanna, L.; Seghini, P.; Di Nunzio, C.; Orlandi, E.; Michieletti, E.; Stroppa, E.M.; Mordenti, P.; Citterio, C.; Vecchia, S.; Zangrandi, A. Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status. Oncol. Lett. 2018, 15, 5787–5791. [Google Scholar] [PubMed]
- Zhang, Y.; Lin, Y.; Duan, J.; Xu, K.; Mao, M.; Wang, X. A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer. Med. Sci. Monit. 2020, 26, e923867. Available online: https://pubmed.ncbi.nlm.nih.gov/32409630/ (accessed on 5 May 2024). [CrossRef] [PubMed]
- Bartelt, S.; Momm, F.; Weissenberger, C.; Lutterbach, J. Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: Prognostic factors and survival. World J. Gastroenterol. 2004, 10, 3345–3348. [Google Scholar] [CrossRef] [PubMed]
- Kawasaki, A.; Suzuki, K.; Takekawa, H.; Nakamura, T.; Yamamoto, M.; Asakawa, Y.; Okamura, M.; Hirata, K. Co-occurrence of multiple cerebral infarctions due to hypercoagulability associated with malignancy and meningeal carcinomatosis as the initial manifestation of gastric cancer. BMC Neurol. 2014, 14, 160. [Google Scholar] [CrossRef] [PubMed]
- Guo, J.W.; Zhang, X.T.; Chen, X.S.; Zhang, X.C.; Zheng, G.J.; Zhang, B.P.; Cai, Y.F. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: A case report. World J. Gastroenterol. 2014, 20, 2120–2126. [Google Scholar] [CrossRef] [PubMed]
- Ohno, T.; Yokoyama, Y.; Aihara, R.; Mochiki, E.; Asao, T.; Kuwano, H. Sudden bilateral sensorineural hearing loss as the presenting symptom of meningeal carcinomatosis of gastric cancer: Report of a case. Surg. Today 2010, 40, 561–565. [Google Scholar] [CrossRef] [PubMed]
- Vergoulidou, M. Leptomeningeal Carcinomatosis in Gastric Cancer: A Therapeutical Challenge. Biomark. Insights 2017, 12, 1177271917695237. [Google Scholar] [CrossRef] [PubMed]
- Singh, S.R.; Malapati, S.J.; Mattour, A. Leptomeningeal Carcinomatosis. In Cancer Metastasis Through the Lymphovascular System; Springer International Publishing: Cham, Switzerland, 2023; pp. 575–583. [Google Scholar]
- Le Rhun, E.; Weller, M.; Bent, M.v.D.; Brandsma, D.; Furtner, J.; Rudà, R.; Schadendorf, D.; Seoane, J.; Tonn, J.-C.; Wesseling, P.; et al. Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open 2023, 8, 101624. [Google Scholar] [CrossRef]
- Ino, R.; Sada, K.-E.; Miyauchi, A.; Hashimoto, D.; Nojima, S.; Yamanaka, S.; Kawamura, M. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer. Acta Medica Okayama 2021, 75, 659–661. [Google Scholar]
- Mittica, G.; Senetta, R.; Richiardi, L.; Rudà, R.; Coda, R.; Castellano, I.; Sapino, A.; Cassoni, P. Meningeal carcinomatosis underdiagnosis and overestimation: Incidence in a large consecutive and unselected population of breast cancer patients. BMC Cancer 2015, 15, 1021. Available online: https://pubmed.ncbi.nlm.nih.gov/26715407/ (accessed on 5 May 2024). [CrossRef] [PubMed]
- Pentheroudakis, G.; Pavlidis, N. Management of leptomeningeal malignancy. Expert Opin. Pharmacother. 2005, 6, 1115–1125. [Google Scholar] [CrossRef]
- Rubió-Casadevall, J.; Carbó-Bagué, A.; Puigdemont, M.; Osca-Gelis, G.; Oliveras, G.; Vilar-Coromina, N.; Ferrer-Fabrega, B.; Urban, A.; Llobet-Roma, M.; Martín-Romero, F.; et al. Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor. Eur. J. Dermatol. 2021, 31, 616–622. Available online: https://pubmed.ncbi.nlm.nih.gov/34789445/ (accessed on 5 May 2024). [CrossRef]
- Ferguson, S.D.; Bindal, S.; Bassett, R.L.; Haydu, L.E.; McCutcheon, I.E.; Heimberger, A.B.; Li, J.; O’brien, B.J.; Guha-Thakurta, N.; Tetzlaff, M.T.; et al. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J. Neuro-Oncol. 2019, 142, 499–509. Available online: https://pubmed.ncbi.nlm.nih.gov/30847840/ (accessed on 5 May 2024). [CrossRef]
- Fuchizaki, U.; Ohta, H.; Kaneko, S. Image of the Month: David M. Warshauer, Section Editor. Gastroenterology 2005, 128, 1773. [Google Scholar] [CrossRef] [PubMed]
- Braeuninger, S.; Mawrin, C.; Malfertheiner, P.; Schildhaus, H.-U.; Seiler, C.; Dietzmann, K.; Lins, H. Gastric adenocarcinoma with leptomeningeal carcinomatosis as the presenting manifestation: An autopsy case report. Eur. J. Gastroenterol. Hepatol. 2005, 17, 577–579. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.G.; Lee, B.; Kim, S.M.; Suh, B.J.; Yu, H.J. A Case of Gastric Adenocarcinoma Presenting as Meningeal Carcinomatosis. Korean J. Intern. Med. 2007, 22, 304–307. [Google Scholar] [CrossRef]
- Cresto, N.; Barth, A.; Arnold, M.; Weimann, R.; Gschossmann, J.; Ochsenbein, A.F.; Kolotas, C.; Peter, H.J.; Schiemann, U. Extraordinary manifestation of a gastric carcinoma by leptomeningeal carcinomatosis and spinal metastasis. Med. Klin. 2007, 102, 255–258. [Google Scholar] [CrossRef]
- Suto, C.; Oohira, A.; Funaki, C.; Kanno, S.; Mori, Y. Pathological findings of optic neuropathy from metastatic leptomeningeal carcinomatosis. Jpn. J. Ophthalmol. 2007, 51, 396–398. [Google Scholar] [CrossRef] [PubMed]
- Yamada, T.; Furukawa, K.; Yokoi, K.; Ohaki, Y.; Okada, S.; Tajiri, T. A case of meningeal carcinomatosis with gastric cancer which manifested meningeal signs as the initial symptom; the palliative benefit of radiotherapy. J. Nippon. Med. Sch. 2008, 75, 216–220. [Google Scholar] [CrossRef]
- Silverman, A.; Loube, D.; Lovall, M.; Cheronis, C.; Madill, E.; Karch, C. Teaching NeuroImage: Cutaneous Lesions and Leptomeningeal Carcinomatosis in Gastric Signet-Ring Cell Carcinoma. Neurology 2023, 101, E1104–E1105. [Google Scholar] [CrossRef] [PubMed]
- Le Rhun, E.; Devos, P.; Winklhofer, S.; Lmalem, H.; Brandsma, D.; Kumthekar, P.; Castellano, A.; Compter, A.; Dhermain, F.; Franceschi, E.; et al. Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. Neuro Oncol. 2022, 24, 1726–1735. Available online: https://pubmed.ncbi.nlm.nih.gov/35157772/ (accessed on 5 May 2024). [CrossRef]
- Kim, M. Intracranial involvement by metastatic advanced gastric carcinoma. J. Neuro-Oncol. 1999, 43, 59–62. Available online: https://pubmed.ncbi.nlm.nih.gov/10448872/ (accessed on 5 May 2024). [CrossRef]
- Baccili Cury Megid, T.; Baskurt, Z.; Ma, L.X.; Barron, C.C.; Farooq, A.; Saltiel, M.P.; Wang, X.; Bach, Y.; Ayoama, H.; Jang, R.W.; et al. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: A real-world analysis of clinical and pathologic characteristics and outcomes. J. Neurooncol. 2024, 167, 111–122. Available online: https://pubmed.ncbi.nlm.nih.gov/38372902/ (accessed on 5 May 2024). [CrossRef] [PubMed]
- Le Rhun, E.; Devos, P.; Weller, J.; Seystahl, K.; Mo, F.; Compter, A.; Berghoff, A.S.; Jongen, J.L.M.; Wolpert, F.; Rudà, R.; et al. Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncol. 2021, 23, 1100–1112. Available online: https://pubmed.ncbi.nlm.nih.gov/33367859/ (accessed on 5 May 2024). [CrossRef]
- Singh, S.K.; Agris, J.M.; Leeds, N.E.; Ginsberg, L.E. Intracranial leptomeningeal metastases: Comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology 2000, 217, 50–53. [Google Scholar] [CrossRef] [PubMed]
- Clarke, J.; Perez, H.; Jacks, L.; Panageas, K.; DeAngelis, L. Leptomeningeal metastases in the MRI era. Neurology 2010, 74, 1449–1454. [Google Scholar] [CrossRef] [PubMed]
- van Oostenbrugge, R.; Twijnstra, A. Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999, 53, 382. [Google Scholar] [CrossRef] [PubMed]
- Balm, M.; Hammack, J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch. Neurol. 1996, 53, 626–632. [Google Scholar] [CrossRef] [PubMed]
- Weston, C.L.; Glantz, M.J.; Connor, J.R. Detection of cancer cells in the cerebrospinal fluid: Current methods and future directions. Fluids Barriers CNS 2011, 8, 14. [Google Scholar] [CrossRef] [PubMed]
- Lucarini, A.; Garbarino, G.M.; Orlandi, P.; Garofalo, E.; Bragaglia, L.; Laracca, G.G.; Canali, G.; Pecoraro, A.; Mercantini, P. From “Cure” to “Care”: The Role of the MultiDisciplinary Team on Colorectal Cancer Patients’ Satisfaction and Oncological Outcomes. J. Multidiscip. Health 2022, 15, 1415–1426. Available online: https://www.dovepress.com/from-cure-to-care-the-role-of-the-multidisciplinary-team-on-colorectal-peer-reviewed-fulltext-article-JMDH (accessed on 5 May 2024). [CrossRef]
- Mercantini, P.; Lucarini, A.; Mazzuca, F.; Osti, M.F.; Laghi, A. How technology can help in oncologic patient management during COVID-19 outbreak. Eur. J. Surg. Oncol. (EJSO) 2020, 46, 1189–1191. Available online: https://pubmed.ncbi.nlm.nih.gov/32389524/ (accessed on 5 May 2024). [CrossRef]
- Al-Batran, S.E.; Homann, N.; Pauligk, C.; Illerhaus, G.; Martens, U.M.; Stoehlmacher, J.; Schmalenberg, H.; Luley, K.B.; Prasnikar, N.; Egger, M.; et al. Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients with Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial. JAMA Oncol. 2017, 3, 1237–1244. [Google Scholar] [CrossRef]
Study | Country and Year | Age and Sex | Clinical Presentation | Pathology | Treatment | Outcome |
---|---|---|---|---|---|---|
Fuchizaki U et al. [23] | Japan, 2005 | 42, male | Unsteady gait, ataxia, dysmetria | Signet ring cell carcinoma | Chemotherapy | Deceased 49 days after diagnosis |
Braeuninger S et al. [24] | Germany, 2005 | 68, male | Vertigo, diplopia, nausea, vomiting | Poorly differentiated carcinoma | Intrathecal methotrexate | Deceased 2 months after diagnosis |
Lee G H et al. [25] | South Korea, 2007 | 49, female | Headache, dizziness, easy fatigability, and melena | Signet ring cell carcinoma | Supportive care | NR |
Cresto N et al. [26] | Switzerland, 2007 | 57, NR | Nocturnal limb hypoesthesia and paresthesia, visual impairment | Signet ring cell carcinoma | NR | NR |
Suto C et al. [27] | Japan, 2007 | 70, male | Optic neuropathy | Signet ring cell carcinoma | NR | Deceased 3 months after diagnosis |
Yamada T et al. [28] | Japan, 2008 | 53, male | Anorexia, intermitting diplopia, general fatigue, headache, vertigo | Poorly differentiated carcinoma | Whole-brain RT | Deceased 127 days after diagnosis |
Ohno T et al. [14] | Japan, 2010 | 62, male | Bilateral hearing loss | Poorly differentiated carcinoma | Whole-brain RT + S1 + Paclitaxel | Deceased 12 weeks after diagnosis |
Kawasaki A et al. [12] | Japan, 2014 | 80, female | Headache, nausea, fever | Signet ring cell carcinoma | Supportive care | NR |
Guo J-W et al. [13] | China, 2014 | 40, female | Headache and cervical pain | Signet ring cell carcinoma | Supportive care | Deceased 2 months after diagnosis |
Vergoulidou M [15] | Germany, 2017 | 48, female | Headache and nausea | Signet ring cell carcinoma | Intrathecal methotrexate + systemic FLOT | Deceased 2 months after diagnosis |
Ino R et al. [18] | Japan, 2021 | 77, female | General malaise, posterior neck pain, gait disturbance | Poorly differentiated carcinoma | NR | Deceased 25 days after diagnosis |
Silverman A et al. [29] | USA, 2023 | 61, male | Positional headache, blurry vision, early satiety, weight loss | Signet ring cell carcinoma | NR | NR |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lucarini, A.; Arrivi, G.; Liotta, E.; Li Causi, F.S.; Di Cicco, L.; Mazzuca, F.; Osti, M.F.; Balducci, G.; Mercantini, P. Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review. Healthcare 2024, 12, 1184. https://doi.org/10.3390/healthcare12121184
Lucarini A, Arrivi G, Liotta E, Li Causi FS, Di Cicco L, Mazzuca F, Osti MF, Balducci G, Mercantini P. Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review. Healthcare. 2024; 12(12):1184. https://doi.org/10.3390/healthcare12121184
Chicago/Turabian StyleLucarini, Alessio, Giulia Arrivi, Elena Liotta, Francesco Saverio Li Causi, Leonardo Di Cicco, Federica Mazzuca, Mattia Falchetto Osti, Genoveffa Balducci, and Paolo Mercantini. 2024. "Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review" Healthcare 12, no. 12: 1184. https://doi.org/10.3390/healthcare12121184
APA StyleLucarini, A., Arrivi, G., Liotta, E., Li Causi, F. S., Di Cicco, L., Mazzuca, F., Osti, M. F., Balducci, G., & Mercantini, P. (2024). Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review. Healthcare, 12(12), 1184. https://doi.org/10.3390/healthcare12121184